rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Javier B. Szwarcberg

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, Spruce Biosciences.

In numbers

Trades disclosed
45
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
3 Jan 2022
Last trade
30 Jun 2026
Last filed
9 Jul 2026

Companies traded

Where they are an officer
SPRB Spruce BiosciencesDirector, Officer · Biotechnology · last 30 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
30 Jun 2026filed 9 Jul 2026SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code A$1,205266 at $4.53filing
30 Jun 2026filed 9 Jul 2026SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code A$1,205266 at $4.53filing
31 Dec 2025filed 5 Jan 2026SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code A$21K4,690 at $4.53filing
31 Dec 2025filed 5 Jan 2026SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code A$21K4,690 at $4.53filing
15 Dec 2025filed 17 Dec 2025SPRB Spruce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—1,480 at $0.00filing
15 Dec 2025filed 17 Dec 2025SPRB Spruce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—1,196 at $0.00filing
15 Dec 2025filed 17 Dec 2025SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code M—1,480 at $0.00filing
15 Dec 2025filed 17 Dec 2025SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code F$61K752 at $80.67filing
15 Dec 2025filed 17 Dec 2025SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code M—1,196 at $0.00filing
15 Dec 2025filed 17 Dec 2025SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code F$49K608 at $80.67filing
11 Dec 2025filed 17 Dec 2025SPRB Spruce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—1,666filing
11 Dec 2025filed 17 Dec 2025SPRB Spruce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—1,666filing
11 Dec 2025filed 15 Dec 2025SPRB Spruce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—10,000filing
11 Dec 2025filed 15 Dec 2025SPRB Spruce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—10,000filing
11 Dec 2025filed 12 Dec 2025SPRB Spruce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—19,800 at $0.00filing
11 Dec 2025filed 12 Dec 2025SPRB Spruce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—4,950 at $0.00filing
11 Dec 2025filed 12 Dec 2025SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code M—4,950 at $0.00filing
11 Dec 2025filed 12 Dec 2025SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code F$194K2,194 at $88.41filing
10 Dec 2025filed 12 Dec 2025SPRB Spruce Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—1,196 at $0.00filing
10 Dec 2025filed 12 Dec 2025SPRB Spruce BiosciencesBiotechnologySEC FORM 4 Code M—1,196 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Adrian W. QuartelChief Medical Officer · Chief Medical Officer at Spruce Biosciences, filing Form 4 there in the last year
Michael G. GreyDirector · Executive Chairman at Spruce Biosciences, filing Form 4 there in the last year
Keli WalbertDirector · Director at Spruce Biosciences, filing Form 4 there in the last year
Camilla Simpson VDirector · Director at Spruce Biosciences, filing Form 4 there in the last year
Percival Barretto-KoDirector · Director at Spruce Biosciences, filing Form 4 there in the last year